Harvard Bioscience (HBIO) EPS (Weighted Average and Diluted) Growth (3y) (2013 - 2026)
Harvard Bioscience (HBIO) EPS (Weighted Average and Diluted) Growth (3y) (2013 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Weighted Avg. Diluted) Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Intuitive Surgical | 148.09 Bn | 143.69 Bn | 1.83 Bn | 31.62% |
| 2 | Becton Dickinson | 41.00 Bn | 39.99 Bn | 2.15 Bn | -39.68% |
| 3 | Medline | 30.38 Bn | 36.22 Bn | 1.84 Bn | - |
| 4 | Resmed | 28.22 Bn | 26.56 Bn | 890.98 Mn | 20.14% |
| 5 | West Pharmaceutical Services | 23.72 Bn | 23.19 Bn | 296.40 Mn | 1.25% |
| 6 | Solventum | 13.33 Bn | 13.33 Bn | 1.10 Bn | - |
| 7 | Cooper Companies | 13.12 Bn | 12.99 Bn | 735.40 Mn | -58.74% |
| 8 | Align Technology | 12.86 Bn | 11.80 Bn | 736.59 Mn | 11.26% |
| 9 | Baxter International | 10.51 Bn | 8.47 Bn | 891.00 Mn | -32.64% |
| 10 | Harvard Bioscience | 26.17 Mn | 19.07 Mn | 12.24 Mn | -328.26% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -328.26% |
| Dec 31, 2025 | -13.59% |
| Jun 30, 2023 | 20.63% |
| Mar 31, 2023 | 27.72% |
| Dec 31, 2022 | -66.46% |
| Jun 30, 2022 | 100.00% |
| Mar 31, 2022 | -41.50% |
| Jun 30, 2021 | 37.00% |
| Jun 30, 2020 | -58.74% |
| Mar 31, 2020 | -81.71% |
| Dec 31, 2019 | 35.72% |
| Sep 30, 2019 | -11.87% |
| Jun 30, 2019 | 20.63% |
| Mar 31, 2019 | -44.22% |
| Dec 31, 2018 | 29.59% |
| Sep 30, 2018 | 20.63% |
| Jun 30, 2018 | -81.71% |
| Mar 31, 2018 | -40.10% |
| Sep 30, 2017 | -35.72% |
| Jun 30, 2017 | -32.64% |